Company Filing History:
Years Active: 1990-2000
Title: Innovations by L. Edward Cannon: A Pioneer in Immunoassay Technology
Introduction
L. Edward Cannon, an accomplished inventor based in Wayland, Massachusetts, has significantly contributed to the field of immunoassay technology. With a total of four patents to his name, Cannon's innovative work has paved the way for improved detection procedures in medical diagnostics. He is currently associated with Hygeia Sciences, Inc., where he continues to advance scientific research and development.
Latest Patents
Cannon's latest inventions highlight his expertise in creating advanced immunoassay kits and procedures. One of his notable patents is the "Sol Capture Immunoassay Kit and Procedure," designed for the detection of analytes in urine. This innovative procedure facilitates a more accurate diagnosis by utilizing a filterable immunocomposite and inherently colored gold sol particles. The kit minimizes false positive readings through multiple mechanisms, ensuring reliable results.
Another significant invention is the "Simultaneous Dual Analyte Assay," which focuses on determining the fertile period of the human menstrual cycle. This assay employs a combination of reaction components that allow for the precise detection of P-3-G and E-1-3-G hormones in an aqueous sample. By calibrating the assay to specific concentration criteria, Cannon has created a tool that visually indicates results with a high degree of accuracy.
Career Highlights
Throughout his career, L. Edward Cannon has demonstrated a commitment to innovation and excellence within the scientific community. His work at Hygeia Sciences, Inc. exemplifies his dedication to advancing healthcare solutions. The technologies he has developed not only enhance diagnostic accuracy but also improve patient outcomes through better-informed medical decisions.
Collaborations
Cannon's successful patents are often the result of collaboration with talented colleagues in the field. Notable coworkers such as Eric C. Sigillo and Francis X. Cole have contributed valuable insights and expertise, aiding in the refinement of Cannon's innovative projects. Together, they have fostered a collaborative environment that encourages the pursuit of groundbreaking advancements in immunoassay technology.
Conclusion
L. Edward Cannon stands out as a prominent figure in the development of immunoassay technologies. His inventiveness and collaborative spirit have resulted in innovative tools that significantly impact medical diagnostics. With his ongoing work at Hygeia Sciences, Inc. and a proven track record of successful patents, Cannon continues to shape the future of the healthcare landscape.